Homo sapiens Protein: SLC2A1
Summary
InnateDB Protein IDBP-381854.4
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol SLC2A1
Protein Name solute carrier family 2 (facilitated glucose transporter), member 1
Synonyms DYT17; DYT18; DYT9; EIG12; GLUT; GLUT-1; GLUT1; GLUT1DS; HTLVR; PED;
Species Homo sapiens
Ensembl Protein ENSP00000416293
InnateDB Gene IDBG-97330 (SLC2A1)
Protein Structure
UniProt Annotation
Function Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses. {ECO:0000269PubMed:18245775, ECO:0000269PubMed:19449892}.
Subcellular Localization Cell membrane; Multi-pass membrane protein. Melanosome. Note=Localizes primarily at the cell surface. Identified by mass spectrometry in melanosome fractions from stage I to stage IV.
Disease Associations GLUT1 deficiency syndrome 1 (GLUT1DS1) [MIM:606777]: A neurologic disorder showing wide phenotypic variability. The most severe 'classic' phenotype comprises infantile-onset epileptic encephalopathy associated with delayed development, acquired microcephaly, motor incoordination, and spasticity. Onset of seizures, usually characterized by apneic episodes, staring spells, and episodic eye movements, occurs within the first 4 months of life. Other paroxysmal findings include intermittent ataxia, confusion, lethargy, sleep disturbance, and headache. Varying degrees of cognitive impairment can occur, ranging from learning disabilities to severe mental retardation. {ECO:0000269PubMed:10227690, ECO:0000269PubMed:10980529, ECO:0000269PubMed:11136715, ECO:0000269PubMed:11603379, ECO:0000269PubMed:12325075, ECO:0000269PubMed:15622525, ECO:0000269PubMed:19901175, ECO:0000269PubMed:20129935, ECO:0000269PubMed:20221955, ECO:0000269PubMed:20574033}. Note=The disease is caused by mutations affecting the gene represented in this entry.GLUT1 deficiency syndrome 2 (GLUT1DS2) [MIM:612126]: A clinically variable disorder characterized primarily by onset in childhood of paroxysmal exercise-induced dyskinesia. The dyskinesia involves transient abnormal involuntary movements, such as dystonia and choreoathetosis, induced by exercise or exertion, and affecting the exercised limbs. Some patients may also have epilepsy, most commonly childhood absence epilepsy. Mild mental retardation may also occur. In some patients involuntary exertion- induced dystonic, choreoathetotic, and ballistic movements may be associated with macrocytic hemolytic anemia. {ECO:0000269PubMed:14605501, ECO:0000269PubMed:18451999, ECO:0000269PubMed:19630075, ECO:0000269PubMed:19798636, ECO:0000269PubMed:20129935, ECO:0000269PubMed:20574033, ECO:0000269PubMed:20621801, ECO:0000269PubMed:20830593, ECO:0000269PubMed:21204808}. Note=The disease is caused by mutations affecting the gene represented in this entry.Epilepsy, idiopathic generalized 12 (EIG12) [MIM:614847]: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Seizure types include juvenile myoclonic seizures, absence seizures, and generalized tonic-clonic seizures. In some EIG12 patients seizures may remit with age. {ECO:0000269PubMed:19798636, ECO:0000269PubMed:22282645}. Note=The disease is caused by mutations affecting the gene represented in this entry.Dystonia 9 (DYT9) [MIM:601042]: An autosomal dominant neurologic disorder characterized by childhood onset of paroxysmal choreoathetosis and progressive spastic paraplegia. Most patients show some degree of cognitive impairment. Other variable features may include seizures, migraine headaches, and ataxia. {ECO:0000269PubMed:21832227}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity Detected in erythrocytes (at protein level). Expressed at variable levels in many human tissues. {ECO:0000269PubMed:23219802}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 21 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Experimentally validated
Total 21 [view]
Protein-Protein 20 [view]
Protein-DNA 1 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005355 glucose transmembrane transporter activity
GO:0005515 protein binding
GO:0019900 kinase binding
GO:0022857 transmembrane transporter activity
GO:0022891 substrate-specific transmembrane transporter activity
GO:0033300 dehydroascorbic acid transporter activity
GO:0042802 identical protein binding
GO:0042910 xenobiotic transporter activity
GO:0043621 protein self-association
GO:0055056 D-glucose transmembrane transporter activity
Biological Process
GO:0005975 carbohydrate metabolic process
GO:0006112 energy reserve metabolic process
GO:0006461 protein complex assembly
GO:0006766 vitamin metabolic process
GO:0006767 water-soluble vitamin metabolic process
GO:0006970 response to osmotic stress
GO:0008645 hexose transport
GO:0015758 glucose transport
GO:0019852 L-ascorbic acid metabolic process
GO:0042149 cellular response to glucose starvation
GO:0042908 xenobiotic transport
GO:0044281 small molecule metabolic process
GO:0050796 regulation of insulin secretion
GO:0055085 transmembrane transport
GO:0070837 dehydroascorbic acid transport
Cellular Component
GO:0001939 female pronucleus
GO:0005622 intracellular
GO:0005737 cytoplasm
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0005901 caveola
GO:0005911 cell-cell junction
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0016323 basolateral plasma membrane
GO:0030496 midbody
GO:0030864 cortical actin cytoskeleton
GO:0031982 vesicle
GO:0042470 melanosome
GO:0070062 extracellular vesicular exosome
GO:0072562 blood microparticle
Protein Structure and Domains
PDB ID
InterPro IPR002439 Glucose transporter, type 1 (GLUT1)
IPR003663 Sugar/inositol transporter
IPR005828 General substrate transporter
IPR011701 Major facilitator superfamily
IPR016196 Major facilitator superfamily domain, general substrate transporter
IPR020846 Major facilitator superfamily domain
PFAM PF00083
PF07690
PRINTS PR01190
PR00171
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P11166
PhosphoSite PhosphoSite-P11166
TrEMBL Q59GX2
UniProt Splice Variant
Entrez Gene 6513
UniGene Hs.473721
RefSeq NP_006507
HUGO HGNC:11005
OMIM 138140
CCDS CCDS477
HPRD 00683
IMGT
EMBL AB208987 AF070544 AK122999 AK292791 AK312403 AY034633 BC118590 CH471059 K03195 M20653
GenPept AAA52571 AAB61084 AAC28635 AAI18591 AAK56795 BAD92224 BAF85480 BAG35317 BAG53842 EAX07124